News

Building Emotional Resilience When You Have LEMS

Emotional resilience is a term used to describe how people respond to changes in life and their ability to adapt to stressful situations. However, a person being more resilient than another doesn’t mean they don’t experience or feel the stress. Rather, it refers to how quickly they can adapt…

Following Firdapse US Launch, Catalyst Estimates 2019 Revenues of $102M

Catalyst Pharmaceuticals expects to report 2019 net product revenues of $102 million for Firdapse (amifampridine), the first and only therapy available for treating the symptoms of Lambert-Eaton myasthenic syndrome (LEMS). In addition, the biopharmaceutical company anticipates 2020 Firdapse net product revenues of $135 million to $155…

Video: BioNews’ Social Media Campaign Highlights #WhatMakesMeRare

In recognition of Rare Disease Day Feb. 29, BioNews Services launched a social media campaign last month asking patients to describe what makes them rare. Running Feb. 7–29, the #WhatMakesMeRare campaign was aimed at uplifting people with rare diseases by encouraging them to share their stories and perspectives. The…

Rare Case of Overlapping LEMS and Myasthenia Gravis May Help Spur Research Into More Antigen-specific Therapies, Study Says

The case of a 55-year-old woman diagnosed with overlapping Lambert-Eaton myasthenic syndrome and myasthenia gravis — which tested negative for well-known neuromuscular junction antibodies — could help pave the way for further research into better, target-specific therapies, a study suggests. The study, “A Case of Triple-Negative Myasthenia…

Patients, Supporters Worldwide Recognizing Rare Disease Day 2020

An abundance of events are afoot around the world to mark Rare Disease Day 2020 on Feb. 29. The activities are focused on heightening awareness about rare diseases and the hundreds of millions of individuals they are thought to affect. Patients, caregivers, and advocates worldwide will sport denim ribbons…